Meiji Yasuda Asset Management Co Ltd.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1491685
Tokyo, M0
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,328,340
+$2,336,273 QoQ
Shares Held
12,740
+42.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#431
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meiji Yasuda Asset Management Co Ltd. holds $10,170,872 across 12 Biotechnology names. VRTX ranks #1 (62.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
12,740 | $6,328,340 | |
| 2 | INCY |
Incyte Corp
|
5,097 | $577,795 | |
| 3 | RPRX |
Royalty Pharma plc
|
8,098 | $454,054 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,780 | $445,171 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
10,402 | $368,126 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,452 | $349,888 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,085 | $326,617 | |
| 8 | EXEL |
Exelixis, Inc.
|
5,818 | $316,557 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,328,340 | 12,740 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,992,067 | 8,940 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,180,432 | 9,221 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $3,720,580 | 9,500 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,288,611 | 9,633 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,131,033 | 12,646 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $5,341,010 | 13,263 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,078,595 | 13,070 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,051,175 | 12,910 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $2,457,062 | 5,878 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,767,394 | 9,259 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,891,458 | 8,315 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,854,213 | 5,269 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,680,583 | 5,334 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,613,459 | 9,050 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,758,950 | 19,890 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $5,712,165 | 20,271 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $5,773,178 | 22,122 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $5,096,037 | 23,206 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,160,179 | 22,935 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,541,715 | 22,525 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,883,805 | 22,727 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,098,562 | 21,573 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,332,966 | 15,923 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,203,226 | 17,923 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,145,491 | 4,814 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||